Clinical trial
Improving Tumor Oxygenation in Cervical Cancer With Methazolamide
NCT00257829 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Improving Tumor Oxygenation in Cervical Cancer With Methazolamide
- Lead sponsor
- University of California, Irvine
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- July 31, 2004
- Completion date
- September 20, 2006
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer